AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 294: H1335-H1347, 2008. First published January 11, 2008; doi:10.1152/ajpheart.00584.2007
0363-6135/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/3/H1335    most recent
00584.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, M.
Right arrow Articles by Mende, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, M.
Right arrow Articles by Mende, U.

Enhanced calcium cycling and contractile function in transgenic hearts expressing constitutively active G{alpha}o* protein

Ming Zhu,1,2 Agnieszka A. Gach,2 GongXin Liu,1,2 Xiaomei Xu,2 Chee Chew Lim,3 Julie X. Zhang,2 Lan Mao,4 Kurt Chuprun,5 Walter J. Koch,5 Ronglih Liao,2,3 Gideon Koren,1,2 Burns C. Blaxall,6 and Ulrike Mende1,2

1Division of Cardiology, Rhode Island Hospital and The Warren Alpert Medical School of Brown University, Providence, Rhode Island; 2Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; 3Boston University School of Medicine, Boston, Massachusetts; 4Department of Medicine, Duke University Medical Center, Durham, North Carolina; 5Thomas Jefferson University, Philadelphia, Pennsylvania; and 6University of Rochester, Rochester, New York

Submitted 18 May 2007 ; accepted in final form 5 January 2008

In contrast to the other heterotrimeric GTP-binding proteins (G proteins) Gs and Gi, the functional role of Go is still poorly defined. To investigate the role of G{alpha}o in the heart, we generated transgenic mice with cardiac-specific expression of a constitutively active form of G{alpha}o1* (G{alpha}o*), the predominant G{alpha}o isoform in the heart. G{alpha}o expression was increased 3- to 15-fold in mice from 5 independent lines, all of which had a normal life span and no gross cardiac morphological abnormalities. We demonstrate enhanced contractile function in G{alpha}o* transgenic mice in vivo, along with increased L-type Ca2+ channel current density, calcium transients, and cell shortening in ventricular G{alpha}o*-expressing myocytes compared with wild-type controls. These changes were evident at baseline and maintained after isoproterenol stimulation. Expression levels of all major Ca2+ handling proteins were largely unchanged, except for a modest reduction in Na+/Ca2+ exchanger in transgenic ventricles. In contrast, phosphorylation of the ryanodine receptor and phospholamban at known PKA sites was increased 1.6- and 1.9-fold, respectively, in G{alpha}o* ventricles. Density and affinity of β-adrenoceptors, cAMP levels, and PKA activity were comparable in G{alpha}o* and wild-type myocytes, but protein phosphatase 1 activity was reduced upon G{alpha}o* expression, particularly in the vicinity of the ryanodine receptor. We conclude that G{alpha}o* exerts a positive effect on Ca2+ cycling and contractile function. Alterations in protein phosphatase 1 activity rather than PKA-mediated phosphorylation might be involved in hyperphosphorylation of key Ca2+ handling proteins in hearts with constitutive G{alpha}o activation.

G proteins; signal transduction; calcium; contraction; transgenic mice



Address for reprint requests and other correspondence: U. Mende, Cardiovascular Research Center, Division of Cardiology, Rhode Island Hospital, Coro Center, 5thfloor, Rm. 5105, 1 Hoppin St., Providence, RI 02903 (e-mail: Ulrike_Mende{at}brown.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. W. Adams, J. Wang, J. R. Davis, C. Liaw, I. Gaidarov, J. Gatlin, N. D. Dalton, Y. Gu, J. Ross Jr., D. Behan, et al.
Myocardial expression, signaling, and function of GPR22: a protective role for an orphan G protein-coupled receptor
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H509 - H521.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. I. Kontaridis, W. Yang, K. K. Bence, D. Cullen, B. Wang, N. Bodyak, Q. Ke, A. Hinek, P. M. Kang, R. Liao, et al.
Deletion of Ptpn11 (Shp2) in Cardiomyocytes Causes Dilated Cardiomyopathy via Effects on the Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase and RhoA Signaling Pathways
Circulation, March 18, 2008; 117(11): 1423 - 1435.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.